FDA clears 3DICOM MD Cloud: What this means for Singular Health’s U.S. expansion and diagnostic imaging disruption
The U.S. Food and Drug Administration has granted 510(k) clearance to Singular Health Limited’s 3DICOM MD Cloud platform, expanding the Australian company’s regulated product portfolio in the United States. This marks the second FDA approval for the company’s medical imaging software line, following the clearance of its desktop-based 3DICOM MD Viewer in October 2022. The […]